Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer (Q40640745)

22 September 2017

Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer (English)

1 reference

22 September 2017

0 references

1 reference

1

Avraham Eisbruch

1 reference

22 September 2017

Teresa Lyden

2

1 reference

22 September 2017

Carol R Bradford

3

1 reference

22 September 2017

Laura A Dawson

4

1 reference

22 September 2017

Marc J Haxer

5

1 reference

22 September 2017

Amy E Miller

6

1 reference

22 September 2017

Theodoros N Teknos

7

1 reference

22 September 2017

Douglas B Chepeha

8

1 reference

22 September 2017

Norman D Hogikyan

9

1 reference

22 September 2017

Jeffrey E Terrell

10

1 reference

22 September 2017

Gregory T Wolf

11

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Radiation Oncology Biology Physics

22 September 2017

1 reference

22 September 2017

53

1 reference

22 September 2017

23-28

1 reference

22 September 2017

1

1 reference

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Split-course accelerated therapy in head and neck cancer: an analysis of toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Altered fractionation: limited by mucosal reactions?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Toxicity in head and neck cancer: a review of trends and issues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Pretreatment swallowing function in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Swallowing function in patients with head and neck cancer prior to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Dysphagia after radiotherapy: endoscopic examination of swallowing in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Pharyngeal transport dysfunction consequent to an organ-sparing protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Dysphagia in treated nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Aspiration pneumonitis and aspiration pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Aspiration pneumonia. Clinical outcome following documented aspiration.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Dose-response analysis for nasopharyngeal carcinoma: an historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Late effects of radiation therapy in the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Videofluoroscopic evidence of aspiration predicts pneumonia and death but not dehydration following stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Aspiration: cause and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

The association of swallowing dysfunction and aspiration pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Effects of postural change on aspiration in head and neck surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

Super-supraglottic swallow in irradiated head and neck cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902712-8

7 January 2021

10.1016/S0360-3016(02)02712-8

Identifiers

DOI

1 reference

22 September 2017

1 reference